Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group

CONCLUSION: Data from this large real-life dataset suggested that maintenance with niraparib in the real-life setting of platinum sensitive OC recurrence is effective and well tolerated.PMID:38277918 | DOI:10.1016/j.ygyno.2024.01.022

Source: Gynecologic Oncology - January 26, 2024 Category: Cancer & Oncology Authors: Lucia Musacchio Eleonora Palluzzi Marilena Di Napoli Rossella Lauria Gabriella Ferrandina Roberto Angioli Alice Bergamini Giacomo Corrado Giorgia Perniola Chiara Cassani Antonella Savarese Stefania Gori Filippo Greco Carmine De Angelis Elena Zafarana Dian Source Type: research